Ina Sternberger, SVP In vitro Biology, is responsible for In vitro biology activities at Evotec in different areas including neurodegeneration, inflammation, fibrosis and phenotypic drug discovery. Activities are reaching from target identification and validation, and supporting lead optimisation to candidate selection. Ina joined Evotec in 2008 as a biologist in cellular assay development and high throughput screening and has since worked in various roles. Ina has led various target centric and phenotypic discovery programs in Cancer Immunotherapy and regenerative medicine. Before joining Evotec, Ina worked on neurodegenerative diseases both in Big Pharma and Small Biotech. Ina holds a PhD in biochemistry. Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.